CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market buy Director bought 30,000 shares at $1.55 ($46,404)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC TO-I Deal Tender Offer Statement by Issuer
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale SVP, FINANCE AND CAO sold 564 shares at $2.58 ($1,455)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 1,365 shares at $2.58 ($3,522)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 761 shares (to pay taxes)
- 4 Open-market sale PRESIDENT & CSO sold 1,937 shares at $2.58 ($4,997)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 2,191 shares (to pay taxes)
Page 7 of 22 · 421 filings